These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8117848

  • 1. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H, Knoblich A.
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [Abstract] [Full Text] [Related]

  • 2. Clinical potential of intravenously administered perfluorocarbons.
    Habler O, Kleen M, Messmer K.
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract] [Full Text] [Related]

  • 3. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG.
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [Abstract] [Full Text] [Related]

  • 4. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE, Malinoff SH, Pelura TJ.
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [Abstract] [Full Text] [Related]

  • 5. 19F Oximetry with semifluorinated alkanes.
    Kegel S, Chacon-Caldera J, Tsagogiorgas C, Theisinger B, Glatting G, Schad LR.
    Artif Cells Nanomed Biotechnol; 2016 Dec; 44(8):1861-1866. PubMed ID: 26631543
    [Abstract] [Full Text] [Related]

  • 6. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J, Reichelt H.
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [Abstract] [Full Text] [Related]

  • 7. Perfluoroalklylated phospholipids as surfactants and co-surfactants forinjectable fluorocarbon emulsions.
    Santaella C, Vierling P, Riess JG.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Nov; 20(2-4):835-7. PubMed ID: 1391518
    [Abstract] [Full Text] [Related]

  • 8. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs.
    Agarwal P, Scherer D, Günther B, Rupenthal ID.
    Int J Pharm; 2018 Mar 01; 538(1-2):119-129. PubMed ID: 29339249
    [Abstract] [Full Text] [Related]

  • 9. On the perfluorocarbon emulsions of second generation.
    Meinert H, Fackler R, Knoblich A, Mader J, Reuter P, Röhlke W.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Mar 01; 20(2-4):805-18. PubMed ID: 1391515
    [Abstract] [Full Text] [Related]

  • 10. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG, Postel M.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Mar 01; 20(2-4):819-30. PubMed ID: 1391516
    [Abstract] [Full Text] [Related]

  • 11. Perfluorocarbons and semifluorinated alkanes.
    Wong D, Lois N.
    Semin Ophthalmol; 2000 Mar 01; 15(1):25-35. PubMed ID: 10749312
    [Abstract] [Full Text] [Related]

  • 12. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
    Johnson JL, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC.
    Artif Cells Blood Substit Immobil Biotechnol; 2009 Mar 01; 37(4):156-62. PubMed ID: 19548131
    [Abstract] [Full Text] [Related]

  • 13. Microemulsions of perfluorinated and semi-fluorinated compounds.
    Lattes A, Rico-Lattes I.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Mar 01; 22(4):1007-18. PubMed ID: 7849905
    [Abstract] [Full Text] [Related]

  • 14. Semifluorinated Alkanes as New Drug Carriers-An Overview of Potential Medical and Clinical Applications.
    Tsagogiorgas C, Otto M.
    Pharmaceutics; 2023 Apr 11; 15(4):. PubMed ID: 37111696
    [Abstract] [Full Text] [Related]

  • 15. Amphiphilic sugar phosphates with single or double perfluoroalkylated hydrophobic chains for use in oxygen and drug delivery systems.
    Guillod F, Greiner J, Milius A, Riess JG.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Apr 11; 22(4):1273-9. PubMed ID: 7849933
    [Abstract] [Full Text] [Related]

  • 16. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N, Mehra A.
    ASAIO J; 1996 Apr 11; 42(3):181-9. PubMed ID: 8725685
    [Abstract] [Full Text] [Related]

  • 17. [The toxicity of surface-active substances for emulsifying perfluorocarbon compounds as components of blood substitute preparations].
    Draffehn J, Reichelt H.
    Pharmazie; 1991 Apr 11; 46(4):271-2. PubMed ID: 1886917
    [Abstract] [Full Text] [Related]

  • 18. Blood substitutes made on the basis of perfluorocarbons inhibit intracellular energy generation.
    Reichelt H, Draffehn J, Rüdiger S, Gross U.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Apr 11; 20(2-4):1021-3. PubMed ID: 1391420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T, Lenz C, Waschke KF.
    Dtsch Med Wochenschr; 2000 Apr 14; 125(15):465-72. PubMed ID: 10800445
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.